The effect of Nano-curcumin in patients with diabetic hemodialysis

Phase 3

• Conditions: Chronic kidney disease.; Chronic kidney disease, stage 5; N18.5

• Registration Number: IRCT20150606022562N6
• Lead Sponsor: Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Diabetic hemodialysis patients
Aged 18to 80 years

Exclusion Criteria

Patients suffering from infectious, inflammatory and malignant diseases.
Patients taking curcumin supplements, antioxidant and/or anti-inflammatory supplements within 3 months before participation in the study.
subjects receiving immunosuppressive and antibiotics medications.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insulin. Timepoint: At the beginning of the study and 12 weeks after intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and after 24 weeks of intervention. Method of measurement: Calculation using HOMA formula.